These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 19879672

  • 1. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
    Katalinić M, Rusak G, Domaćinović Barović J, Sinko G, Jelić D, Antolović R, Kovarik Z.
    Eur J Med Chem; 2010 Jan; 45(1):186-92. PubMed ID: 19879672
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R, Lin X, Zhang J, Chol KS, Huang W, Yang B, He Q, Hu Y.
    Bioorg Med Chem; 2009 Sep 15; 17(18):6692-8. PubMed ID: 19692250
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cholinesterase inhibitors from Cleistocalyx operculatus buds.
    Min BS, Cuong TD, Lee JS, Shin BS, Woo MH, Hung TM.
    Arch Pharm Res; 2010 Oct 15; 33(10):1665-70. PubMed ID: 21052942
    [Abstract] [Full Text] [Related]

  • 7. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A, Worek F, Szinicz L, Thiermann H.
    Toxicology; 2007 Apr 20; 233(1-3):166-72. PubMed ID: 16904809
    [Abstract] [Full Text] [Related]

  • 8. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
    Musilek K, Komloova M, Holas O, Hrabinova M, Pohanka M, Dohnal V, Nachon F, Dolezal M, Kuca K.
    Eur J Med Chem; 2011 Feb 20; 46(2):811-8. PubMed ID: 21236521
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE, Park JY, No KT, Shin JH, Lee SK, Eun JS, Yang JH, Shin TY, Kim DK, Chae BS, Leem JY, Kim KH.
    Bioorg Med Chem; 2007 Oct 15; 15(20):6596-607. PubMed ID: 17681794
    [Abstract] [Full Text] [Related]

  • 10. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
    Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O.
    Biochem Pharmacol; 2005 Nov 25; 70(11):1673-84. PubMed ID: 16213467
    [Abstract] [Full Text] [Related]

  • 11. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers.
    Bosak A, Gazić I, Vinković V, Kovarik Z.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):192-5. PubMed ID: 18582854
    [Abstract] [Full Text] [Related]

  • 12. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
    Orhan IE, Jedrejek D, Senol FS, Salmas RE, Durdagi S, Kowalska I, Pecio L, Oleszek W.
    Phytomedicine; 2018 Mar 15; 42():25-33. PubMed ID: 29655693
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Isolation of cholinesterase-inhibiting flavonoids from Morus lhou.
    Kim JY, Lee WS, Kim YS, Curtis-Long MJ, Lee BW, Ryu YB, Park KH.
    J Agric Food Chem; 2011 May 11; 59(9):4589-96. PubMed ID: 21434689
    [Abstract] [Full Text] [Related]

  • 16. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
    Li H, Schopfer LM, Nachon F, Froment MT, Masson P, Lockridge O.
    Toxicol Sci; 2007 Nov 11; 100(1):136-45. PubMed ID: 17698511
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G, Palacios-Esquivel R, Moss DE.
    J Pharmacol Exp Ther; 1995 Aug 11; 274(2):767-70. PubMed ID: 7636741
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.